Cognitive Function Is Superior In Breast Cancer Patients Treated With Letrozole Versu

[News]

New results show that postmenopausal women with breast cancer receiving adjuvant letrozole have better cognitive function than women being treated with tamoxifen. The data, from a recent meeting of the American Society of Clinical Oncology (ASCO), are drawn from a sub-study of the Breast International Group (BIG) 1-98 trial.

More... (http://www.medicalnewstoday.com/articles/157658.php)